Potential of Natural Products as Therapeutic Agents for Inflammatory Diseases


Citar

Texto integral

Resumo

:Inflammation is a complex biological response that plays a pivotal role in various pathological conditions, including inflammatory diseases. The search for effective therapeutic agents has led researchers to explore natural products due to their diverse chemical composition and potential therapeutic benefits. This review comprehensively examines the current state of research on natural products as potential therapeutic agents for inflammatory diseases. The article discusses the antiinflammatory properties of various natural compounds, their mechanisms of action, and their potential applications in managing inflammatory disorders. Additionally, formulation and delivery systems, challenges and future prospects in this field are also highlighted.

Sobre autores

Chintan Aundhia

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University

Autor responsável pela correspondência
Email: info@benthamscience.net

Ghanshyam Parmar

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University

Email: info@benthamscience.net

Chitrali Talele

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University

Email: info@benthamscience.net

Piyushkumar Sadhu

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University

Email: info@benthamscience.net

Ashim Sen

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University

Email: info@benthamscience.net

Pramojeeta Rana

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University

Email: info@benthamscience.net

Bibliografia

  1. Botero, JSH; Pérez, MCF The history of sepsis from ancient Egypt to the XIX century. In: Sepsis-an ongoing and significant challenge; Intechopen, 2012.
  2. Hannoodee, S.; Nasuruddin, D.N. Acute Inflammatory Response; StatPearls Publishing: Treasure Island, FL, 2023.
  3. Granger, D.N.; Senchenkova, E. Inflammation and the Microcirculation; Morgan & Claypool Publishers, 2010. doi: 10.4199/C00013ED1V01Y201006ISP008
  4. Janeway, C.A., Jr; Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol., 2002, 20(1), 197-216. doi: 10.1146/annurev.immunol.20.083001.084359 PMID: 11861602
  5. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 2018, 9(6), 7204-7218. doi: 10.18632/oncotarget.23208 PMID: 29467962
  6. Pahwa, R; Goyal, A; Bansal, P; Jialal, I. Chronic inflammation. In: StatPearls ; StatPearls Publishing: Treasure Island (FL), 2024.
  7. Hannoodee, S; Nasuruddin, DN Acute inflammatory response. In: StatPearls ; StatPearls Publishing: Treasure Island (FL), 2024.
  8. Furman, D.; Campisi, J.; Verdin, E.; Carrera-Bastos, P.; Targ, S.; Franceschi, C.; Ferrucci, L.; Gilroy, D.W.; Fasano, A.; Miller, G.W.; Miller, A.H.; Mantovani, A.; Weyand, C.M.; Barzilai, N.; Goronzy, J.J.; Rando, T.A.; Effros, R.B.; Lucia, A.; Kleinstreuer, N.; Slavich, G.M. Chronic inflammation in the etiology of disease across the life span. Nat. Med., 2019, 25(12), 1822-1832. doi: 10.1038/s41591-019-0675-0 PMID: 31806905
  9. Bennett, J.M.; Reeves, G.; Billman, G.E.; Sturmberg, J.P. Inflammation–nature’s way to efficiently respond to all types of challenges: Implications for understanding and managing "the epidemic" of chronic diseases. Front. Med., 2018, 5, 316. doi: 10.3389/fmed.2018.00316 PMID: 30538987
  10. Sugimoto, M.A.; Sousa, L.P.; Pinho, V.; Perretti, M.; Teixeira, M.M. Resolution of inflammation: What controls its onset? Front. Immunol., 2016, 7, 160. doi: 10.3389/fimmu.2016.00160 PMID: 27199985
  11. Gallo, J.; Raska, M.; Kriegova, E.; Goodman, S.B. Inflammation and its resolution and the musculoskeletal system. J. Orthop. Translat., 2017, 10, 52-67. doi: 10.1016/j.jot.2017.05.007 PMID: 28781962
  12. Schilrreff, P.; Alexiev, U. Chronic inflammation in non-healing skin wounds and promising natural bioactive compounds treatment. Int. J. Mol. Sci., 2022, 23(9), 4928. doi: 10.3390/ijms23094928 PMID: 35563319
  13. Coutinho, A.E.; Chapman, K.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol., 2011, 335(1), 2-13. doi: 10.1016/j.mce.2010.04.005 PMID: 20398732
  14. Krensky, A.M.; Vincenti, F.; Bennett, W.M. Immunosuppressants, tolerogens, and immunostimulants. in chief Goodman% Gilman’s the pharmacological basis of therapeutics, 11th ed; McGraw-Hill Companies, Inc.: New York, 2006, pp. 1405-1431.
  15. Leone, G.M.; Mangano, K.; Petralia, M.C.; Nicoletti, F.; Fagone, P. Past, present and (Foreseeable) future of biological anti-TNF alpha therapy. J. Clin. Med., 2023, 12(4), 1630. doi: 10.3390/jcm12041630 PMID: 36836166
  16. Zhao, H.; Wu, L.; Yan, G.; Chen, Y.; Zhou, M.; Wu, Y.; Li, Y. Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal Transduct. Target. Ther., 2021, 6(1), 263. doi: 10.1038/s41392-021-00658-5 PMID: 34248142
  17. Ghlichloo, I; Gerriets, V. Nonsteroidal anti-inflammatory drugs (NSAIDs). In: StatPearls ; StatPearls Publishing: Treasure Island (FL), 2024.
  18. Fleischman, A.N.; Li, W.T.; Luzzi, A.J.; Van Nest, D.S.; Torjman, M.C.; Schwenk, E.S.; Arnold, W.A.; Parvizi, J. Risk of gastrointestinal bleeding with extended use of nonsteroidal anti-inflammatory drug analgesia after joint arthroplasty. J. Arthroplasty, 2021, 36(6), 1921-1925.e1. doi: 10.1016/j.arth.2021.02.015 PMID: 33642110
  19. Sinniah, A.; Yazid, S.; Flower, R.J. From NSAIDs to glucocorticoids and beyond. Cells, 2021, 10(12), 3524. doi: 10.3390/cells10123524 PMID: 34944032
  20. Moghadam-Kia, S.; Werth, V.P. Prevention and treatment of systemic glucocorticoid side effects. Int. J. Dermatol., 2010, 49(3), 239-248. doi: 10.1111/j.1365-4632.2009.04322.x PMID: 20465658
  21. Bosani, M.; Ardizzone, S.; Porro, G.B. Biologic targeting in the treatment of inflammatory bowel diseases. Biologics, 2009, 3, 77-97. PMID: 19707398
  22. Pichler, W.J. Adverse side‐effects to biological agents. Allergy, 2006, 61(8), 912-920. doi: 10.1111/j.1398-9995.2006.01058.x PMID: 16867042
  23. Sobhani, M.; Farzaei, M.H.; Kiani, S.; Khodarahmi, R. Immunomodulatory; Anti-inflammatory/antioxidant effects of polyphenols: A comparative review on the parental compounds and their metabolites. Food Rev. Int., 2021, 37(8), 759-811. doi: 10.1080/87559129.2020.1717523
  24. Kassim, M.; Achoui, M.; Mustafa, M.R.; Mohd, M.A.; Yusoff, K.M. Ellagic acid, phenolic acids, and flavonoids in Malaysian honey extracts demonstrate in vitro anti-inflammatory activity. Nutr. Res., 2010, 30(9), 650-659. doi: 10.1016/j.nutres.2010.08.008 PMID: 20934607
  25. Zhang, L.; Ravipati, A.S.; Koyyalamudi, S.R.; Jeong, S.C.; Reddy, N.; Smith, P.T.; Bartlett, J.; Shanmugam, K.; Münch, G.; Wu, M.J. Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. J. Agric. Food Chem., 2011, 59(23), 12361-12367. doi: 10.1021/jf203146e PMID: 22023309
  26. Karak, P. Biological activities of flavonoids: An overview. Int. J. Pharm. Sci. Res., 2019, 10(4), 1567-1574.
  27. Panche, A.N.; Diwan, A.D.; Chandra, S.R. Flavonoids: An overview. J. Nutr. Sci., 2016, 5, e47. doi: 10.1017/jns.2016.41 PMID: 28620474
  28. Wang, X.; Cao, Y.; Chen, S.; Lin, J.; Bian, J.; Huang, D. Anti-inflammation activity of flavones and their structure–activity relationship. J. Agric. Food Chem., 2021, 69(26), 7285-7302. doi: 10.1021/acs.jafc.1c02015 PMID: 34160206
  29. Rathee, P; Chaudhary, H; Rathee, S; Rathee, D; Kumar, V; Kohli, K Mechanism of action of flavonoids as anti-inflammatory agents: A review. Inflamm Allergy Drug Targets, 2009, 8(3), 229-235. doi: 10.2174/187152809788681029
  30. Devi, K.P.; Kiruthiga, P.V.; Pandian, S.K. Emerging role of flavonoids in inhibition of NF-κB-mediated signaling pathway: A review. Int J Biomed Pharm Sci., 2009, 3(1), 31-45.
  31. Wu, Y.; Zhou, C.; Li, X.; Song, L.; Wu, X.; Lin, W.; Chen, H.; Bai, H.; Zhao, J.; Zhang, R.; Sun, H.; Zhao, Y. Evaluation of antiinflammatory activity of the total flavonoids of Laggera pterodonta on acute and chronic inflammation models. Phytother. Res., 2006, 20(7), 585-590. doi: 10.1002/ptr.1918 PMID: 16673449
  32. Zhao, J; Maitituersun, A; Li, C; Li, Q; Xu, F; Liu, T Evaluation on analgesic and anti-inflammatory activities of total flavonoids from Juniperus sabina. Evid Based Complement Alternat Med., 2018, 2018, 7965306. doi: 10.1155/2018/7965306
  33. Giménez-Bastida, J.A.; González-Sarrías, A.; Laparra-Llopis, J.M.; Schneider, C.; Espín, J.C. Targeting mammalian 5-lipoxygenase by dietary phenolics as an anti-inflammatory mechanism: A systematic review. Int. J. Mol. Sci., 2021, 22(15), 7937. doi: 10.3390/ijms22157937 PMID: 34360703
  34. Khan, H.; Ullah, H.; Castilho, P.C.M.F.; Gomila, A.S.; D’Onofrio, G.; Filosa, R.; Wang, F.; Nabavi, S.M.; Daglia, M.; Silva, A.S.; Rengasamy, K.R.R.; Ou, J.; Zou, X.; Xiao, J.; Cao, H. Targeting NF-κB signaling pathway in cancer by dietary polyphenols. Crit. Rev. Food Sci. Nutr., 2020, 60(16), 2790-2800. doi: 10.1080/10408398.2019.1661827 PMID: 31512490
  35. Taofiq, O.; Calhelha, R.C.; Heleno, S.; Barros, L.; Martins, A.; Santos-Buelga, C.; Queiroz, M.J.R.P.; Ferreira, I.C.F.R. The contribution of phenolic acids to the anti-inflammatory activity of mushrooms: Screening in phenolic extracts, individual parent molecules and synthesized glucuronated and methylated derivatives. Food Res. Int., 2015, 76(Pt 3), 821-827. doi: 10.1016/j.foodres.2015.07.044 PMID: 28455068
  36. dos Santos, M.D.; Almeida, M.C.; Lopes, N.P.; de Souza, G.E.P. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull., 2006, 29(11), 2236-2240. doi: 10.1248/bpb.29.2236 PMID: 17077520
  37. Dhifi, W.; Bellili, S.; Jazi, S.; Bahloul, N.; Mnif, W. Essential oils’ chemical characterization and investigation of some biological activities: A critical review. Medicines, 2016, 3(4), 25. doi: 10.3390/medicines3040025 PMID: 28930135
  38. Quintans, J.S.S.; Shanmugam, S.; Heimfarth, L.; Araújo, A.A.S.; Almeida, J.R.G.S.; Picot, L.; Quintans-Júnior, L.J. Monoterpenes modulating cytokines - A review. Food Chem. Toxicol., 2019, 123, 233-257. doi: 10.1016/j.fct.2018.10.058 PMID: 30389585
  39. Rodrigues, T.G.; Fernandes, A., Jr; Sousa, J.P.B.; Bastos, J.K.; Sforcin, J.M. In vitro and in vivo effects of clove on pro-inflammatory cytokines production by macrophages. Nat. Prod. Res., 2009, 23(4), 319-326. doi: 10.1080/14786410802242679 PMID: 19296372
  40. Wang, J; Song, Y; Chen, Z; Leng, SX Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in neurodegenerative diseases. Oxid Med Cell Longev, 2018, 2018, 1972714. doi: 10.1155/2018/1972714
  41. Siani, A.C.; Ramos, M.F.S.; Menezes-de-Lima, O., Jr; Ribeiro-dos-Santos, R.; Fernadez-Ferreira, E.; Soares, R.O.A.; Rosas, E.C.; Susunaga, G.S.; Guimarães, A.C.; Zoghbi, M.G.B.; Henriques, M.G.M.O. Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. J. Ethnopharmacol., 1999, 66(1), 57-69. doi: 10.1016/S0378-8741(98)00148-2 PMID: 10432208
  42. Silva, J.; Abebe, W.; Sousa, S.M.; Duarte, V.G.; Machado, M.I.L.; Matos, F.J.A. Analgesic and anti-inflammatory effects of essential oils of Eucalyptus. J. Ethnopharmacol., 2003, 89(2-3), 277-283. doi: 10.1016/j.jep.2003.09.007 PMID: 14611892
  43. Kashyap, D.; Sharma, A.; Tuli, H.S.; Punia, S.; Sharma, A.K. Ursolic acid and oleanolic acid: Pentacyclic terpenoids with promising anti-inflammatory activities. Recent Pat. Inflamm. Allergy Drug Discov., 2016, 10(1), 21-33. doi: 10.2174/1872213X10666160711143904 PMID: 27531153
  44. Chen, M.; Qin, Y.; Ma, H.; Zheng, X.; Zhou, R.; Sun, S.; Huang, Y.; Duan, Q.; Liu, W.; Wu, P.; Xu, X.; Sheng, Z.; Zhang, K.; Li, D. Downregulating NF-κB signaling pathway with triterpenoids for attenuating inflammation: In vitro and in vivo studies. Food Funct., 2019, 10(8), 5080-5090. doi: 10.1039/C9FO00561G PMID: 31361289
  45. Hohmann, MSN; Longhi-Balbinot, DT; Guazelli, CFS; Navarro, SA; Zarpelon, AC; Casagrande, R Sesquiterpene lactones: Structural diversity and perspectives as anti-inflammatory molecules. Stud Nat Prod Chem, 2016, 49, 243-264.
  46. Matos, M.S.; Anastácio, J.D.; Nunes dos Santos, C. Sesquiterpene lactones: Promising natural compounds to fight inflammation. Pharmaceutics, 2021, 13(7), 991. doi: 10.3390/pharmaceutics13070991 PMID: 34208907
  47. Fattori, V.; Hohmann, M.; Rossaneis, A.; Pinho-Ribeiro, F.; Verri, W., Jr Capsaicin: Current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules, 2016, 21(7), 844. doi: 10.3390/molecules21070844 PMID: 27367653
  48. Lee, I.O.; Lee, K.H.; Pyo, J.H.; Kim, J.H.; Choi, Y.J.; Lee, Y.C. Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter, 2007, 12(5), 510-517. doi: 10.1111/j.1523-5378.2007.00521.x PMID: 17760719
  49. Zheng, Q.; Sun, W.; Qu, M. Anti-neuro-inflammatory effects of the bioactive compound capsaicin through the NF-κB signaling pathway in LPS-stimulated BV2 microglial cells. Pharmacogn. Mag., 2018, 14(58)
  50. Silva, R.C.M.C.; Tan, L.; Rodrigues, D.A.; Prestes, E.B.; Gomes, C.P.; Gama, A.M.; Oliveira, P.L.; Paiva, C.N.; Manoury, B.; Bozza, M.T. Chloroquine inhibits pro-inflammatory effects of heme on macrophages and in vivo. Free Radic. Biol. Med., 2021, 173, 104-116. doi: 10.1016/j.freeradbiomed.2021.07.028 PMID: 34303829
  51. Brindha, P. Role of phytochemicals as immunomodulatory agents: A review. Int. J. Green Pharm., 2016, 10(1)
  52. Galvão, I; Sugimoto, MA; Vago, JP; Machado, MG; Sousa, LP Mediators of inflammation. In: Mediators of Inflammation. ; Springer, Cham, 2018; pp. 3-32.
  53. Sakthivel, K.M.; Guruvayoorappan, C. Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-(TNF-a, iNOS, COX-2, IL-1β, IL-6, IFN-γ, IL-2, GM-CSF) and pro-angiogenic growth factor- VEGF. Asian Pac. J. Cancer Prev., 2013, 14(6), 3909-3919. doi: 10.7314/APJCP.2013.14.6.3909 PMID: 23886206
  54. Mohankumar, K.; Francis, A.P.; Pajaniradje, S.; Rajagopalan, R. Synthetic curcumin analog: Inhibiting the invasion, angiogenesis, and metastasis in human laryngeal carcinoma cells via NF-kB pathway. Mol. Biol. Rep., 2021, 48(8), 6065-6074. doi: 10.1007/s11033-021-06610-8 PMID: 34355287
  55. de Vries, J.E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med., 1995, 27(5), 537-541. doi: 10.3109/07853899509002465 PMID: 8541028
  56. Bi, Y; Chen, J; Hu, F; Liu, J; Li, M; Zhao, L. M2 macrophages as a potential target for antiatherosclerosis treatment. Neural Plast., 2019, 2019, 6724903. doi: 10.1155/2019/6724903
  57. Viola, A.; Luster, A.D. Chemokines and their receptors: Drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol., 2008, 48(1), 171-197. doi: 10.1146/annurev.pharmtox.48.121806.154841 PMID: 17883327
  58. Gautam, R.; Jachak, S.M. Recent developments in anti‐inflammatory natural products. Med. Res. Rev., 2009, 29(5), 767-820. doi: 10.1002/med.20156 PMID: 19378317
  59. Keane, M.P.; Strieter, R.M. Chemokine signaling in inflammation. Crit. Care Med., 2000, 28(4)(Suppl.), N13-N26. doi: 10.1097/00003246-200004001-00003 PMID: 10807313
  60. Wang, R.X.; Zhou, M.; Ma, H.L.; Qiao, Y.B.; Li, Q.S. The role of chronic inflammation in various diseases and anti‐inflammatory therapies containing natural products. ChemMedChem, 2021, 16(10), 1576-1592. doi: 10.1002/cmdc.202000996 PMID: 33528076
  61. Rajakariar, R.; Yaqoob, M.M.; Gilroy, D.W. COX-2 in inflammation and resolution. Mol. Interv., 2006, 6(4), 199-207. doi: 10.1124/mi.6.4.6 PMID: 16960142
  62. Yatoo, M.I.; Gopalakrishnan, A.; Saxena, A.; Parray, O.R.; Tufani, N.A.; Chakraborty, S.; Tiwari, R.; Dhama, K.; Iqbal, H.M.N. Anti-inflammatory drugs and herbs with special emphasis on herbal medicines for countering inflammatory diseases and disorders-a review. Recent Pat. Inflamm. Allergy Drug Discov., 2018, 12(1), 39-58. doi: 10.2174/1872213X12666180115153635 PMID: 29336271
  63. Bashir Dar, K.; Hussain Bhat, A.; Amin, S.; Masood, A.; Afzal Zargar, M.; Ahmad Ganie, S. Inflammation: A multidimensional insight on natural anti-inflammatory therapeutic compounds. Curr. Med. Chem., 2016, 23(33), 3775-3800. doi: 10.2174/0929867323666160817163531 PMID: 27538691
  64. Janakiram, N.; Rao, C. Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer. Curr. Mol. Med., 2009, 9(5), 565-579. doi: 10.2174/156652409788488748 PMID: 19601807
  65. Choy, K.W.; Murugan, D.; Leong, X.F.; Abas, R.; Alias, A.; Mustafa, M.R. Flavonoids as natural anti-inflammatory agents targeting nuclear factor-kappa B (NFκB) signaling in cardiovascular diseases: A mini review. Front. Pharmacol., 2019, 10, 1295. doi: 10.3389/fphar.2019.01295 PMID: 31749703
  66. Mobasheri, A.; Henrotin, Y.; Biesalski, H.K.; Shakibaei, M. Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. Int. J. Mol. Sci., 2012, 13(4), 4202-4232. doi: 10.3390/ijms13044202 PMID: 22605974
  67. Xu, L.; Botchway, B.O.A.; Zhang, S.; Zhou, J.; Liu, X. Inhibition of NF-κB signaling pathway by resveratrol improves spinal cord injury. Front. Neurosci., 2018, 12, 690. doi: 10.3389/fnins.2018.00690 PMID: 30337851
  68. Aparicio-Soto, M.; Redhu, D.; Sánchez-Hidalgo, M.; Fernández-Bolaños, J.G.; Alarcón-de-la-Lastra, C.; Worm, M.; Babina, M. Olive‐oil‐derived polyphenols effectively attenuate inflammatory responses of human keratinocytes by interfering with the NF‐κB pathway. Mol. Nutr. Food Res., 2019, 63(21), 1900019. doi: 10.1002/mnfr.201900019 PMID: 31393642
  69. Mandal, S.K.; Debnath, U.; Kumar, A.; Thomas, S.; Mandal, S.C.; Choudhury, M.D.; Palit, P. Natural sesquiterpene lactones in the prevention and treatment of inflammatory disorders and cancer: A systematic study of this emerging therapeutic approach based on chemical and pharmacological aspect. Lett. Drug Des. Discov., 2020, 17(9), 1102-1116. doi: 10.2174/1570180817999200421144007
  70. Park, E.; Song, J.H.; Kim, M.S.; Park, S.H.; Kim, T.S. Costunolide, a sesquiterpene lactone, inhibits the differentiation of pro-inflammatory CD4 + T cells through the modulation of mitogen-activated protein kinases. Int. Immunopharmacol., 2016, 40, 508-516. doi: 10.1016/j.intimp.2016.10.006 PMID: 27756053
  71. Harijith, A.; Ebenezer, D.L.; Natarajan, V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front. Physiol., 2014, 5, 352. doi: 10.3389/fphys.2014.00352 PMID: 25324778
  72. Özenver, N.; Efferth, T. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases. Pharmacol. Res., 2021, 170, 105710. doi: 10.1016/j.phrs.2021.105710 PMID: 34089866
  73. Latz, E.; Xiao, T.S.; Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol., 2013, 13(6), 397-411. doi: 10.1038/nri3452 PMID: 23702978
  74. Yin, H.; Guo, Q.; Li, X.; Tang, T.; Li, C.; Wang, H.; Sun, Y.; Feng, Q.; Ma, C.; Gao, C.; Yi, F.; Peng, J. Curcumin suppresses IL-1β secretion and prevents inflammation through inhibition of the NLRP3 inflammasome. J. Immunol., 2018, 200(8), 2835-2846. doi: 10.4049/jimmunol.1701495 PMID: 29549176
  75. Chen, B.; Zhao, J.; Zhang, R.; Zhang, L.; Zhang, Q.; Yang, H.; An, J. Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis. Nutr. Neurosci., 2022, 25(5), 1078-1099. doi: 10.1080/1028415X.2020.1840035 PMID: 33164705
  76. Sisein, E.A. Biochemistry of free radicals and antioxidants. Scholars Acad. J. Biosci., 2014, 2(2), 110-118.
  77. Truong, V.L.; Jun, M.; Jeong, W.S. Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors, 2018, 44(1), 36-49. doi: 10.1002/biof.1399 PMID: 29193412
  78. Diniz do Nascimento, L.; Moraes, A.A.B.; Costa, K.S.; Pereira Galúcio, J.M.; Taube, P.S.; Costa, C.M.L.; Neves Cruz, J.; de Aguiar Andrade, E.H.; Faria, L.J.G. Bioactive natural compounds and antioxidant activity of essential oils from spice plants: New findings and potential applications. Biomolecules, 2020, 10(7), 988. doi: 10.3390/biom10070988 PMID: 32630297
  79. Macáková, K.; Afonso, R.; Saso, L.; Mladěnka, P. The influence of alkaloids on oxidative stress and related signaling pathways. Free Radic. Biol. Med., 2019, 134, 429-444. doi: 10.1016/j.freeradbiomed.2019.01.026 PMID: 30703480
  80. Akbari, B.; Baghaei-Yazdi, N.; Bahmaie, M.; Mahdavi Abhari, F. The role of plant‐derived natural antioxidants in reduction of oxidative stress. Biofactors, 2022, 48(3), 611-633. doi: 10.1002/biof.1831 PMID: 35229925
  81. Lee, K.W.; Hur, H.J.; Lee, H.J.; Lee, C.Y. Antiproliferative effects of dietary phenolic substances and hydrogen peroxide. J. Agric. Food Chem., 2005, 53(6), 1990-1995. doi: 10.1021/jf0486040 PMID: 15769125
  82. Graßmann, J. Terpenoids as plant antioxidants. Vitam. Horm., 2005, 72, 505-535. doi: 10.1016/S0083-6729(05)72015-X PMID: 16492481
  83. Dumanović, J.; Nepovimova, E.; Natić, M.; Kuča, K.; Jaćević, V. The significance of reactive oxygen species and antioxidant defense system in plants: A concise overview. Front. Plant Sci., 2021, 11, 552969. doi: 10.3389/fpls.2020.552969 PMID: 33488637
  84. Bhadoriya, S.S.; Mangal, A.; Madoriya, N.; Dixit, P. Bioavailability and bioactivity enhancement of herbal drugs by "Nanotechnology": A review. J Curr Pharm Res., 2011, 8(1), 1-7.
  85. Sayed, N.; Khurana, A.; Godugu, C. Pharmaceutical perspective on the translational hurdles of phytoconstituents and strategies to overcome. J. Drug Deliv. Sci. Technol., 2019, 53, 101201. doi: 10.1016/j.jddst.2019.101201
  86. Thakur, L.; Ghodasra, U.; Patel, N.; Dabhi, M. Novel approaches for stability improvement in natural medicines. Pharmacogn. Rev., 2011, 5(9), 48-54. doi: 10.4103/0973-7847.79099 PMID: 22096318
  87. Ranjbar, S.; Emamjomeh, A.; Sharifi, F.; Zarepour, A.; Aghaabbasi, K.; Dehshahri, A.; Sepahvand, A.M.; Zarrabi, A.; Beyzaei, H.; Zahedi, M.M.; Mohammadinejad, R. Lipid-based delivery systems for flavonoids and flavonolignans: Liposomes, nanoemulsions, and solid lipid nanoparticles. Pharmaceutics, 2023, 15(7), 1944. doi: 10.3390/pharmaceutics15071944 PMID: 37514130
  88. Plaza-Oliver, M.; Santander-Ortega, M.J.; Lozano, M.V. Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv. Transl. Res., 2021, 11(2), 471-497. doi: 10.1007/s13346-021-00908-7 PMID: 33528830
  89. Carneiro, S.; Costa Duarte, F.; Heimfarth, L.; Siqueira Quintans, J.; Quintans-Júnior, L.; Veiga Júnior, V.; Neves de Lima, Á. Cyclodextrin–drug inclusion complexes: In vivo and in vitro approaches. Int. J. Mol. Sci., 2019, 20(3), 642. doi: 10.3390/ijms20030642 PMID: 30717337
  90. Lengyel, M.; Kállai-Szabó, N.; Antal, V.; Laki, A.J.; Antal, I. Microparticles, microspheres, and microcapsules for advanced drug delivery. Sci. Pharm., 2019, 87(3), 20. doi: 10.3390/scipharm87030020
  91. Gordillo-Galeano, A.; Mora-Huertas, C.E. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur. J. Pharm. Biopharm., 2018, 133, 285-308. doi: 10.1016/j.ejpb.2018.10.017 PMID: 30463794
  92. Akbari, J.; Saeedi, M.; Ahmadi, F.; Hashemi, S.M.H.; Babaei, A.; Yaddollahi, S.; Rostamkalaei, S.S.; Asare-Addo, K.; Nokhodchi, A. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharm. Dev. Technol., 2022, 27(5), 525-544. doi: 10.1080/10837450.2022.2084554 PMID: 35635506
  93. Lin, C-H.; Chen, C-H.; Lin, Z-C.; Fang, J-Y. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. Yao Wu Shi Pin Fen Xi, 2017, 25(2), 219-234. PMID: 28911663
  94. Begines, B.; Ortiz, T.; Pérez-Aranda, M.; Martínez, G.; Merinero, M.; Argüelles-Arias, F.; Alcudia, A. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials, 2020, 10(7), 1403. doi: 10.3390/nano10071403 PMID: 32707641
  95. Ma, Y.; Cong, Z.; Gao, P.; Wang, Y. Nanosuspensions technology as a master key for nature products drug delivery and In vivo fate. Eur. J. Pharm. Sci., 2023, 185, 106425. doi: 10.1016/j.ejps.2023.106425 PMID: 36934992
  96. Arora, D.; Khurana, B.; Rath, G.; Nanda, S.; Goyal, A.K. Recent advances in nanosuspension technology for drug delivery. Curr. Pharm. Des., 2018, 24(21), 2403-2415. doi: 10.2174/1381612824666180522100251 PMID: 29788880
  97. Chandran, B.; Goel, A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res., 2012, 26(11), 1719-1725. doi: 10.1002/ptr.4639 PMID: 22407780
  98. Gupta, S.C.; Patchva, S.; Aggarwal, B.B. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J., 2013, 15(1), 195-218. doi: 10.1208/s12248-012-9432-8 PMID: 23143785
  99. Ammon, H. Boswellic acids in chronic inflammatory diseases. Planta Med., 2006, 72(12), 1100-1116. doi: 10.1055/s-2006-947227 PMID: 17024588
  100. Siddiqui, M.Z. Boswellia serrata, a potential antiinflammatory agent: An overview. Indian J. Pharm. Sci., 2011, 73(3), 255-261. PMID: 22457547
  101. Grzanna, R.; Lindmark, L.; Frondoza, C.G. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food, 2005, 8(2), 125-132. doi: 10.1089/jmf.2005.8.125 PMID: 16117603
  102. Mashhadi, N.S.; Ghiasvand, R.; Askari, G.; Hariri, M.; Darvishi, L.; Mofid, M.R. Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: Review of current evidence. Int. J. Prev. Med., 2013, 4(Suppl. 1), S36-S42. PMID: 23717767
  103. Kolluru, GK; Bir, SC; Kevil, CG Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med., 2012, 2012, 918267. doi: 10.1155/2012/918267
  104. Chrubasik, S.; Eisenberg, E.; Balan, E.; Weinberger, T.; Luzzati, R.; Conradt, C. Treatment of low back pain exacerbations with willow bark extract: A randomized double-blind study. Am. J. Med., 2000, 109(1), 9-14. doi: 10.1016/S0002-9343(00)00442-3 PMID: 10936472
  105. Chrubasik, S.; Künzel, O.; Model, A.; Conradt, C.; Black, A. Treatment of low back pain with a herbal or synthetic anti-rheumatic: A randomized controlled study. Willow bark extract for low back pain. Br. J. Rheumatol., 2001, 40(12), 1388-1393. doi: 10.1093/rheumatology/40.12.1388 PMID: 11752510
  106. Khan, N.; Mukhtar, H. Tea polyphenols for health promotion. Life Sci., 2007, 81(7), 519-533. doi: 10.1016/j.lfs.2007.06.011 PMID: 17655876
  107. Kim, H.P.; Son, K.H.; Chang, H.W.; Kang, S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci., 2004, 96(3), 229-245. doi: 10.1254/jphs.CRJ04003X PMID: 15539763
  108. Singh, B.N.; Shankar, S.; Srivastava, R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol., 2011, 82(12), 1807-1821. doi: 10.1016/j.bcp.2011.07.093 PMID: 21827739
  109. Piscoya, J.; Rodriguez, Z.; Bustamante, S.A.; Okuhama, N.N.; Miller, M.J.S.; Sandoval, M. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: Mechanisms of action of the species Uncaria guianensis. Inflamm. Res., 2001, 50(9), 442-448. doi: 10.1007/PL00000268 PMID: 11603848
  110. Sandoval, M.; Charbonnet, R.M.; Okuhama, N.N.; Roberts, J.; Krenova, Z.; Trentacosti, A.M.; Miller, M.J.S. Cat’s claw inhibits TNFα production and scavenges free radicals: Role in cytoprotection. Free Radic. Biol. Med., 2000, 29(1), 71-78. doi: 10.1016/S0891-5849(00)00327-0 PMID: 10962207
  111. Gagnier, J.J.; Chrubasik, S.; Manheimer, E. Harpgophytum procumbens for osteoarthritis and low back pain: A systematic review. BMC Complement. Altern. Med., 2004, 4(1), 13. doi: 10.1186/1472-6882-4-13 PMID: 15369596
  112. Wegener, T.; Lüpke, N.P. Treatment of patients with arthrosis of hip or knee with an aqueous extract of Devil’s Claw ( Harpagophytum procumbens DC.). Phytother. Res., 2003, 17(10), 1165-1172. doi: 10.1002/ptr.1322 PMID: 14669250
  113. Eshun, K.; He, Q. Aloe vera: A valuable ingredient for the food, pharmaceutical and cosmetic industries--a review. Crit. Rev. Food Sci. Nutr., 2004, 44(2), 91-96. doi: 10.1080/10408690490424694 PMID: 15116756
  114. Surjushe, A.; Vasani, R.; Saple, D.G. Aloe vera: A short review. Indian J. Dermatol., 2008, 53(4), 163-166. doi: 10.4103/0019-5154.44785 PMID: 19882025
  115. Fu, Y.; Chen, J.; Li, Y.J.; Zheng, Y.F.; Li, P. Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. Food Chem., 2013, 141(2), 1063-1071. doi: 10.1016/j.foodchem.2013.03.089 PMID: 23790887
  116. Viswanathan, P.; Muralidaran, Y.; Ragavan, G. Challenges in oral drug delivery: A nano-based strategy to overcome. In: Nanostructures for oral medicine; Elsevier, 2017; pp. 173-201.
  117. Cech, N.B.; Yu, K. Mass spectrometry for natural products research: Challenges, pitfalls, and opportunities. LC GC N. Am., 2013, 31(11), 938-947.
  118. Pereira, L.; Valado, A. Algae-derived natural products in diabetes and its complications—current advances and future prospects. Life, 2023, 13(9), 1831. doi: 10.3390/life13091831 PMID: 37763235
  119. George, P. Concerns regarding the safety and toxicity of medicinal plants-An overview. J. Appl. Pharm. Sci., 2011, 1(6), 40-44.
  120. van Wyk, A.S.; Prinsloo, G. Health, safety and quality concerns of plant-based traditional medicines and herbal remedies. S. Afr. J. Bot., 2020, 133, 54-62. doi: 10.1016/j.sajb.2020.06.031
  121. Caesar, L.K.; Montaser, R.; Keller, N.P.; Kelleher, N.L. Metabolomics and genomics in natural products research: Complementary tools for targeting new chemical entities. Nat. Prod. Rep., 2021, 38(11), 2041-2065. doi: 10.1039/D1NP00036E PMID: 34787623
  122. Thomford, N.; Senthebane, D.; Rowe, A.; Munro, D.; Seele, P.; Maroyi, A.; Dzobo, K. Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int. J. Mol. Sci., 2018, 19(6), 1578. doi: 10.3390/ijms19061578 PMID: 29799486
  123. Aswad, M.; Rayan, M.; Abu-Lafi, S.; Falah, M.; Raiyn, J.; Abdallah, Z.; Rayan, A. Nature is the best source of anti-inflammatory drugs: Indexing natural products for their anti-inflammatory bioactivity. Inflamm. Res., 2018, 67(1), 67-75. doi: 10.1007/s00011-017-1096-5 PMID: 28956064
  124. Wang, L.C.; Wei, W.H.; Zhang, X.W.; Liu, D.; Zeng, K.W.; Tu, P.F. An integrated proteomics and bioinformatics approach reveals the anti-inflammatory mechanism of carnosic acid. Front. Pharmacol., 2018, 9, 370. doi: 10.3389/fphar.2018.00370 PMID: 29713284
  125. Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The traditional medicine and modern medicine from natural products. Molecules, 2016, 21(5), 559. doi: 10.3390/molecules21050559 PMID: 27136524
  126. Mirsadeghi, S.; Larijani, B. Personalized medicine: Pharmacogenomics and drug development. Acta Med. Iran., 2017, 55(3), 150-165. PMID: 28282716
  127. Gligorijević, V.; Malod-Dognin, N.; Pržulj, N. Integrative methods for analyzing big data in precision medicine. Proteomics, 2016, 16(5), 741-758. doi: 10.1002/pmic.201500396 PMID: 26677817
  128. Rodrigues, T.; Reker, D.; Schneider, P.; Schneider, G. Counting on natural products for drug design. Nat. Chem., 2016, 8(6), 531-541. doi: 10.1038/nchem.2479 PMID: 27219696
  129. Lurie-Luke, E. Product and technology innovation: What can biomimicry inspire? Biotechnol. Adv., 2014, 32(8), 1494-1505. doi: 10.1016/j.biotechadv.2014.10.002 PMID: 25316672

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bentham Science Publishers, 2024